WEBINAR DETAILS
  • When
    Add to calendar
  • About
    Join Aptahem AB for a webinar where the company will present its ongoing preparations for a planned U.S. listing. During the session, management will outline the strategic initiatives undertaken to strengthen the company’s position, attract U.S. institutional investors, and create optimal conditions for financing the upcoming Phase 2 study.
  • Agenda
    • FDA PreCheck Program
    • Expansion of U.S. Intellectual Property Rights
    • Initiatives for Accelerated Regulatory Review in the U.S.
    • Planned U.S. Listing
  • Duration
    1 hour
  • Price
    Free
  • Language
    English
  • OPEN TO
    Everyone
  • Dial-in available
    (listen only)
    Not available.
FEATURED PRESENTERS
  • Webinar hosting presenter

    Mikael Lindstam

    VD & medgrundare
    Mikael has 25 years’ experience in the Swedish start-up industry, during which he has been instrumental in the founding and development of Galecto Biotech, Cyxone, Gabather, Aptahem and nanotechnology companies, Portendo, NM Spintronics and...
    Full Profile
  • Webinar hosting presenter

    Erika Medin

    Webbinariemoderator (Aptahem Programme coordinator & communication specialist)
    Erika Medin has more than 30 years of experience from research-focused companies within the pharmaceutical industry, including Perstorp Pharma and AstraDraco/AstraZeneca. Over the years, Erika Medin has had various positions within administration,...
    Full Profile
HOSTED BY
Powered by BigMarker